Education
About Us
Working with TipRanks
Follow Us
CellSeed Inc. (JP:7776)
:7776
7776 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥354.00 - ¥974.00
Previous CloseN/A
Volume900.50K
Average Volume (3M)428.52K
Market Cap
¥16.40B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Aug 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.36
Shares Outstanding34,666,420
10 Day Avg. Volume261,230
30 Day Avg. Volume428,516
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥526.00Price Target Upside11.68% Upside
Rating ConsensusHold
Number of Analyst Covering0
7776 FAQ
What was CellSeed Inc.’s price range in the past 12 months?
CellSeed Inc. lowest stock price was ¥354.00 and its highest was ¥974.00 in the past 12 months.
What is CellSeed Inc.’s market cap?
CellSeed Inc.’s market cap is ¥16.40B.
When is CellSeed Inc.’s upcoming earnings report date?
CellSeed Inc.’s upcoming earnings report date is Aug 13, 2025 which is in 14 days.
How were CellSeed Inc.’s earnings last quarter?
Currently, no data Available
Is CellSeed Inc. overvalued?
According to Wall Street analysts CellSeed Inc.’s price is currently Undervalued.
Does CellSeed Inc. pay dividends?
CellSeed Inc. does not currently pay dividends.
What is CellSeed Inc.’s EPS estimate?
CellSeed Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CellSeed Inc. have?
CellSeed Inc. has 34,666,420 shares outstanding.
What happened to CellSeed Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CellSeed Inc.?
Currently, no hedge funds are holding shares in JP:7776
Company Description
CellSeed Inc.
CellSeed Inc. (7776) is a biotechnology company specializing in regenerative medicine. The company focuses on the development and commercialization of cell sheet engineering technology, which is used in regenerative treatments for damaged tissues and organs. Their core products and services include cell sheet regenerative therapies and related research and development activities aimed at advancing tissue regeneration technology.
Technical Analysis
StemRIM Inc.
―
Renascience Inc.
―
ReproCELL Inc.
―
StemCell Institute
―
Japan Tissue Engineering Co., Ltd.
―